Arimidex
3.9 (5 customer reviews)Breast cancer that depends on estrogen is commonly treated with hormonal therapy after menopause. Arimidex lowers estrogen production, helping slow estrogen-driven cancer-cell growth.
Product information
Arimidex contains anastrozole, an aromatase inhibitor for post-menopausal women with hormone receptor-positive breast cancer.
Pharmacological classification and active ingredient
Anastrozole belongs to the third-generation aromatase inhibitor class. It is used as oral hormonal therapy and is taken as a tablet.
Ingredients
Arimidex tablets contain anastrozole, a non-steroidal aromatase inhibitor.
Pharmacological classification and active ingredient
Anastrozole belongs to the third-generation aromatase inhibitor class. It is used as oral hormonal therapy and is taken as a tablet.
Therapeutic indications
Arimidex is prescribed for hormone receptor-positive breast cancer in post-menopausal women. It may be used after breast surgery as adjuvant hormonal therapy, for locally advanced disease, or for metastatic breast cancer when estrogen suppression is clinically appropriate.
Hormone receptor-positive means cancer cells carry estrogen receptors, progesterone receptors, or both. These receptors can respond to hormonal signals. Reducing estrogen is useful only when the tumour biology indicates that estrogen contributes to growth.
The WHO describes breast cancer as the most common cancer among women globally, while treatment planning depends on tumour receptors, stage, menopausal status, and previous therapy; the National Cancer Institute also publishes guidance on breast cancer treatment. [2]
Treatment expectations
Arimidex is often part of a long-term oncology plan. The benefit is not judged by whether a person feels a change after a few days. Follow-up focuses on tumour status where relevant, treatment adherence, bone health, joint symptoms, lipid values, and individual recurrence risk.
Treatment duration is set individually by the oncology team. A person may continue therapy for years when the expected reduction in recurrence risk outweighs adverse effects.
Dosage and administration
Arimidex is taken orally as a daily tablet. The amount per intake is set individually for each person rather than being one fixed number. It should be taken at the same time each day and swallowed whole with water.
If a dose is missed, take it when remembered unless the next scheduled dose is close. Do not take two tablets together to compensate. Doubling up does not restore the missed benefit and may increase unwanted effects.
Common administration mistakes include:
- Taking extra tablets after forgetting a dose.
- Stopping because hot flushes or joint pain start before discussing symptom management.
- Splitting or crushing tablets without clinical advice.
- Continuing tamoxifen at the same time when the prescriber has changed hormonal therapy.
- Ignoring new bone pain, swelling, chest discomfort, or unexplained breathlessness.
- Assuming fatigue always comes from Arimidex rather than considering anaemia, thyroid disease, poor sleep, depression, or cancer-related causes.
When not to use it
Arimidex is not for you if you are pregnant, breastfeeding, pre-menopausal without specialist-directed ovarian suppression, or have had an allergic reaction to anastrozole or tablet ingredients.
Use requires careful review when there is:
- Existing osteoporosis, osteopenia, or a history of low-trauma fractures.
- High cholesterol or cardiovascular disease.
- Moderate or severe liver impairment.
- Significant kidney impairment.
- Unexplained vaginal bleeding.
- A history of severe depression or disabling musculoskeletal symptoms during hormonal therapy.
Tamoxifen and estrogen-containing treatments can interfere with the intended estrogen-lowering effect of anastrozole. This includes some hormone replacement therapy products.
When this is not for you
It is intended for post-menopausal women. Estrogen reduction can harm a developing pregnancy, and pregnancy must be avoided during treatment according to the oncology plan.
Tell the oncology team if you have bone-thinning disease, cardiovascular problems, liver or kidney impairment, unexplained vaginal bleeding, or a history of severe depression or disabling joint symptoms. Also tell them about hormone replacement therapy, estrogen products, tamoxifen, and all other medicines or supplements.
Possible side effects
Lower estrogen levels explain many adverse effects of anastrozole. Hot flushes, joint pain, stiffness, weakness, headache, nausea, fatigue, mood changes, and vaginal dryness are reported during treatment. Some people experience symptoms early, while others notice a gradual change in mobility or sleep.
Joint stiffness often affects the hands, knees, hips, feet, or shoulders. In clinical practice, people commonly describe difficulty when first getting out of bed, opening jars, or climbing stairs after sitting for a long period. Gentle movement can ease morning stiffness for some patients.
Anastrozole can also affect cholesterol levels and may be associated with carpal tunnel syndrome. Carpal tunnel symptoms include tingling, numbness, burning pain, or weakness in the thumb, index, middle, and part of the ring finger.
Seek urgent medical assessment for facial swelling, breathing difficulty, chest pain, sudden one-sided weakness, severe skin reactions, or signs of a blood clot such as a painful swollen leg. These symptoms need prompt evaluation rather than self-management.
The EMA product information lists musculoskeletal symptoms, hot flushes, fatigue, nausea, headache, osteoporosis, fractures, and raised cholesterol among recognised effects or risks of anastrozole therapy. [3]
Practical symptom management
Regular low-impact activity can help preserve mobility. Walking, resistance exercises suited to physical ability, stretching, and supervised physiotherapy are practical options when joints feel stiff.
Hot flushes may improve with lightweight clothing, a cool sleeping environment, reduced alcohol intake, and attention to individual triggers such as spicy meals. Some prescription treatments for hot flushes interact with hormonal therapy, so they should be selected by the treating clinician.
How it affects the body
Aromatase is an enzyme that converts androgens into estrogen in tissues such as fat, muscle, and the breast. By blocking aromatase, anastrozole reduces circulating estrogen levels. [1]
For hormone receptor-positive breast cancer, estrogen can act as a growth signal. Arimidex does not destroy cancer cells directly. It reduces the hormonal stimulation that can support their growth.
Aromatase inhibition differs from chemotherapy. Chemotherapy targets rapidly dividing cells, while anastrozole changes the hormonal environment in which estrogen-sensitive cells grow.
Common mistakes
Some people stop Arimidex abruptly after reading that joint pain is common. The better step is to document the symptoms and discuss them, because many causes of pain are treatable and several endocrine options exist.
Another mistake is treating new vaginal bleeding as an expected hormonal effect. Any post-menopausal bleeding needs medical assessment, even when it seems minor.
Skipping bone-density appointments is also risky. Bone loss may be silent until a fracture occurs.
A final issue is self-starting estrogen-containing products for hot flushes or vaginal symptoms. These can conflict with the purpose of estrogen-lowering therapy. Ask the treating team about non-hormonal or locally directed options suited to the cancer history.
Comparison
Hormonal therapy selection depends on menopausal status, cancer stage, previous treatment, coexisting conditions, bone risk, and treatment tolerance. Arimidex, letrozole, exemestane, and tamoxifen act at different points in estrogen signalling.
| Treatment approach | Mechanism and usual role | Key practical difference |
|---|---|---|
| Arimidex — anastrozole | Non-steroidal aromatase inhibitor that reduces estrogen synthesis after menopause | Can contribute to joint symptoms and bone loss |
| Letrozole or exemestane | Letrozole is another non-steroidal aromatase inhibitor; exemestane, also called Aromasin, is a steroidal aromatase inhibitor | A switch may improve tolerability for some people |
| Tamoxifen | Selective estrogen receptor modulator that blocks estrogen receptors in breast tissue | Has different risks, including thromboembolic and uterine effects |
Anastrozole and letrozole reversibly inhibit aromatase. Exemestane binds aromatase differently and is often described as an irreversible steroidal inhibitor. Tamoxifen does not lower estrogen production in the same way; it blocks estrogen receptor activity in breast tissue.
Tamoxifen can reduce the effectiveness of anastrozole when used together, so these therapies are not routinely combined. Switching from one endocrine treatment to another can be part of a planned course, not a sign that treatment has failed.
NICE guidance recognises aromatase inhibitors and tamoxifen as established endocrine options for hormone receptor-positive breast cancer, with treatment choice tailored to clinical circumstances. [4]
What doctors say
Oncology clinicians usually frame Arimidex as a preventive long-game treatment. The aim is sustained estrogen suppression, not a sensation that confirms the tablet is working. Feeling well does not mean the medicine is unnecessary, and having side effects does not mean its cancer benefit has disappeared.
Bone protection is part of treatment planning, not an afterthought. Baseline fracture risk, DEXA findings, vitamin D status, exercise capacity, and previous fractures guide monitoring and supportive care.
Comparison
Common questions
Can Arimidex affect driving or working with machinery?
Arimidex does not usually cause direct sedation, but fatigue, dizziness, headache, or reduced concentration can occur in some people. Avoid driving or operating machinery if these symptoms affect alertness or coordination. EMA product information describes weakness and fatigue among reported reactions to anastrozole treatment. The guidance used in 2018 supports an individual approach based on how the medicine affects daily function. Keep the oncology team informed if alertness changes.
What happens if Arimidex is stopped, and does it need tapering?
Anastrozole does not usually require gradual dose reduction because it does not cause physical dependence. Estrogen production resumes after treatment stops, so stopping can remove the intended hormonal suppression. Do not stop independently, even if symptoms are difficult. The EMA’s 2018 clinical information frames Arimidex as ongoing endocrine treatment where duration is decided by the oncology plan.
Can Arimidex tablets be split, crushed, or chewed?
Swallow Arimidex tablets whole unless the prescriber or dispensing pharmacist has given a specific alternative instruction. Crushing or chewing can make a daily routine harder and may expose a caregiver to drug residue during handling. People who struggle to swallow tablets should raise this before changing the tablet form. The EMA’s 2018 product information identifies Arimidex as an oral tablet treatment.
Which diet, exercise, or habits support treatment with Arimidex?
Weight-bearing activity and resistance exercise can support bone strength and may reduce stiffness, provided the activity is suitable for your health and cancer treatment stage. A balanced diet with adequate protein, calcium, and vitamin D supports general bone health, while smoking and heavy alcohol intake increase fracture risk. The American Society of Clinical Oncology addressed bone health in adults receiving cancer treatment in its 2019 guidance. Individual nutrition plans matter when appetite, weight, or treatment-related nausea are concerns.
Can Arimidex be taken with food or on an empty stomach?
Arimidex may be taken with or without food. Choose the approach that best supports a consistent daily routine. If nausea occurs, taking the tablet after a light meal may feel more comfortable. EMA product information published in 2018 permits administration without a food requirement.
Can Arimidex be combined with tamoxifen or estrogen-containing products?
Tamoxifen can reduce anastrozole levels and may reduce its intended effect when taken at the same time. Estrogen-containing medicines, including some hormone replacement treatments, can also oppose estrogen suppression. Tell the cancer team about all hormonal products before starting them. NICE endocrine-therapy guidance from 2018 supports treatment selection according to the person’s disease and previous hormonal therapy.
Does Arimidex cause joint pain?
Yes. Joint pain and stiffness are well-known effects of aromatase inhibitor therapy and may involve the hands, knees, hips, feet, or shoulders. The symptom can range from mild morning stiffness to pain that interferes with sleep or activity. EMA information from 2018 lists arthralgia and musculoskeletal symptoms with anastrozole. Persistent symptoms should be assessed because exercise support, pain management, imaging, or a treatment change may be appropriate.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Sources
- European Medicines Agency (2018). Arimidex: Summary of Product Characteristics.
- World Health Organization (2024). Breast cancer.
- European Medicines Agency (2018). Arimidex: Package Leaflet.
- National Institute for Health and Care Excellence (2018). Early and locally advanced breast cancer: diagnosis and management.